電気化学バイオセンサー市場の2030年までの予測： タイプ別、用途別、地域別の世界分析

Stratistics MRCによると、世界の電気化学バイオセンサ市場は、2023年に172億7,000万米ドルを占め、予測期間中にCAGR 8.65％で成長し、2030年には308億7,000万米ドルに達すると予測されています。

電気化学バイオセンサーは、電気化学変換器と生物学的認識成分（酵素、抗体、DNAなど）を組み合わせた分析ツールで、特定の分析対象物や生体分子を同定・測定します。認識要素と標的分析物の相互作用によって引き起こされる電気化学反応に基づいて機能します。これらのバイオセンサーは、バイオマーカー、病原体、環境汚染物質など、さまざまな物質を選択的かつ高感度に測定するために頻繁に使用されています。

国際糖尿病連合によると、2035年までに5億9,000万人以上が糖尿病を発症すると予想されており、予測期間を通じて市場が急拡大することを示唆しています。

ポイント・オブ・ケア検査に対する需要の高まり

ポイントオブケア検査への需要の高まりは、電気化学バイオセンサー市場の主要な促進要因となっています。ポイントオブケア検査は、迅速で便利な診断ソリューションを提供し、ヘルスケア専門家が患者のベッドサイドや遠隔地でリアルタイムの判断を下せるようにします。電気化学バイオセンサーは、高感度で迅速な結果が得られるため、こうした用途に適しています。特に緊急時や慢性疾患管理において、病気の早期発見、継続的モニタリング、タイムリーな介入を容易にします。特に資源に乏しい地域では、利用しやすく安価なヘルスケアを重視する傾向が強まっており、ポイントオブケア検査における電気化学バイオセンサの採用を後押しし、市場拡大を牽引しています。

コスト制約

高度なバイオセンサー技術の開発にはコストがかかり、これらのデバイスの値ごろ感に影響を与えます。特に資源が限られたヘルスケア環境や新興市場では、製造コストの高さが普及の妨げになる可能性があります。さらに、精密な品質管理が必要なため製造コストがかさみ、これが市場の成長をさらに抑制しています。

ヘルスケア分野における技術の進歩

ヘルスケア分野における技術の進歩は、電気化学バイオセンサー市場に大きなチャンスをもたらします。小型化、ワイヤレス接続、データ分析の開発が進むにつれ、バイオセンサーはより洗練され、使いやすくなっています。これらの進歩により、リアルタイムモニタリング、遠隔医療アプリケーション、ウェアラブルデバイスへのバイオセンサの統合が可能になり、患者ケアと疾病管理が強化されます。さらに、人工知能やモノのインターネットのような新興技術とバイオセンサーの融合は、その能力をさらに拡大し、革新的な診断およびモニタリング・ソリューションの機会を提供します。

ヘルスケア機器の使用に関する規制課題

ヘルスケア機器の使用に関する厳しい規制は、電気化学バイオセンサー市場に顕著な脅威をもたらします。医療用バイオセンサーの開発と商業化には、保健当局の承認を含む複雑な規制要件の網の目をくぐり抜ける必要があります。このような厳しい規制の遵守には時間とコストがかかり、課題も多いため、製品の上市が遅れたり、市場参入が妨げられたりする可能性があります。さらに、厳しい要件は、中小企業の市場参入を阻害する可能性もあります。

COVID-19の影響：

COVID-19の流行は、電気化学バイオセンサー市場にプラスの影響を与えました。ウイルスを迅速かつ正確に検査するためのバイオセンサーに対する需要が高まる一方で、サプライチェーンや臨床業務の混乱が課題を生み出しました。ポイントオブケア検査ソリューションの必要性とSARS-CoV-2抗体検出用バイオセンサーの開発が技術革新を推進しました。しかし、研究開発活動の遅れやサプライチェーンの制約が、より広範な市場に影響を及ぼしました。パンデミックの後退に伴い、市場は感染症診断以外の多様な用途に焦点を当てて回復すると予想されます。

予測期間中、診断分野が最大となる見込み

診断分野は、迅速かつ正確でユーザーフレンドリーな診断ソリューションに対する需要の高まりから、市場を独占すると予測されます。診断は、バイオマーカー、病原体、疾患関連分子の検出において高い感度と特異性を提供します。臨床診断から環境・食品安全まで幅広い応用が可能なバイオセンサーは、病気の早期発見、モニタリング、研究のための貴重なツールです。診断のためのリアルタイムデータとポイントオブケア検査ポジションを提供するその能力は、セグメント拡大を推進しています。

予測期間中、ポイントオブケア検査分野のCAGRが最も高くなる見込み

ポイントオブケア検査分野は、迅速かつ分散型の診断ソリューションに対する需要の高まりにより、予測期間中に市場を牽引する見通しです。電気化学バイオセンサは、携帯性、迅速な結果、使いやすさを備えており、POCアプリケーションに適しています。ヘルスケア専門家が患者のそばでタイムリーな判断を下せるようにし、より良い疾病管理と早期発見のためのリアルタイムの洞察を提供します。さらに、POC検査は資源が限られた環境、遠隔地、緊急事態において極めて重要です。アクセスしやすく安価なヘルスケアへの世界のシフトに伴い、POC環境における電気化学バイオセンサの採用は急増し、市場成長を促進すると予想されます。

最大シェアの地域：

予測期間中、北米はヘルスケア支出の増加とポイントオブケア検査技術の採用により、最大市場を占めると予測されます。大手バイオテクノロジー企業や製薬企業が存在し、ヘルスケアへの大規模な投資も行われていることから、同地域では技術の進歩や革新的なバイオセンサ・アプリケーションが促進されています。さらに、北米の確立されたヘルスケアシステムと高齢者人口の増加が市場の成長に寄与しており、世界の電気化学バイオセンサー市場で有力なプレーヤーとなっています。

CAGRが最も高い地域：

アジア太平洋地域の電気化学バイオセンサー市場は、ヘルスケア意識の高まり、慢性疾患の有病率の増加、疾患の早期発見への関心の高まりにより、大幅な成長を遂げています。人口が多く多様なこの地域では、診断ツールや医療機器に対する需要が増加傾向にあります。さらに、ヘルスケアインフラを強化するための政府の取り組みや、バイオセンサー技術の技術的進歩が、市場の拡大をさらに後押ししています。

無料カスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

• 企業プロファイル
  • 追加市場プレイヤーの包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データマイニング
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査ソース
  • 1次調査ソース
  • 2次調査ソース
  • 前提条件

第3章 市場動向分析

• 促進要因
• 抑制要因
• 機会
• 脅威
• アプリケーション分析
• 新興市場
• 新型コロナウイルス感染症（COVID-19）の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界の電気化学バイオセンサー市場：タイプ別

• 診断
  • DNAバイオセンサー
  • グルコースバイオセンサー
  • 免疫センサー
  • その他の診断タイプ
• 監視
  • 直接モニタリング
  • 間接的な監視

第6章 世界の電気化学バイオセンサー市場：用途別

• ヘルスケア診断
• ポイントオブケア検査
• 調査
• その他の用途

第7章 世界の電気化学バイオセンサー市場：地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他欧州
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他アジア太平洋地域
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他南米
• 中東とアフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他中東とアフリカ

第8章 主な発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品の発売
• 事業拡大
• その他の主要戦略

第9章 企業プロファイル

• Abbott Laboratories
• Bayer AG
• Bio-Rad Laboratories
• Biosensors International Group Ltd.
• Conductive Technologies Inc.
• I-SENS, Inc
• Medtronics
• Philips Healthcare
• Roche Holding AG
• Siemens Healthineers
• Sysmex Corporation
• Thermo Fisher Scientific

List of Tables

• Table 1 Global Electrochemical Biosensors Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global Electrochemical Biosensors Market Outlook, By Type (2021-2030) ($MN)
• Table 3 Global Electrochemical Biosensors Market Outlook, By Diagnosis (2021-2030) ($MN)
• Table 4 Global Electrochemical Biosensors Market Outlook, By DNA Biosensors (2021-2030) ($MN)
• Table 5 Global Electrochemical Biosensors Market Outlook, By Glucose Biosensors (2021-2030) ($MN)
• Table 6 Global Electrochemical Biosensors Market Outlook, By Immunosensors (2021-2030) ($MN)
• Table 7 Global Electrochemical Biosensors Market Outlook, By Other Diagnosis types (2021-2030) ($MN)
• Table 8 Global Electrochemical Biosensors Market Outlook, By Monitoring (2021-2030) ($MN)
• Table 9 Global Electrochemical Biosensors Market Outlook, By Direct Monitoring (2021-2030) ($MN)
• Table 10 Global Electrochemical Biosensors Market Outlook, By Indirect Monitoring (2021-2030) ($MN)
• Table 11 Global Electrochemical Biosensors Market Outlook, By Application (2021-2030) ($MN)
• Table 12 Global Electrochemical Biosensors Market Outlook, By Healthcare Diagnostics (2021-2030) ($MN)
• Table 13 Global Electrochemical Biosensors Market Outlook, By Point Of Care Testing (2021-2030) ($MN)
• Table 14 Global Electrochemical Biosensors Market Outlook, By Research Laboratories (2021-2030) ($MN)
• Table 15 Global Electrochemical Biosensors Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 16 North America Electrochemical Biosensors Market Outlook, By Country (2021-2030) ($MN)
• Table 17 North America Electrochemical Biosensors Market Outlook, By Type (2021-2030) ($MN)
• Table 18 North America Electrochemical Biosensors Market Outlook, By Diagnosis (2021-2030) ($MN)
• Table 19 North America Electrochemical Biosensors Market Outlook, By DNA Biosensors (2021-2030) ($MN)
• Table 20 North America Electrochemical Biosensors Market Outlook, By Glucose Biosensors (2021-2030) ($MN)
• Table 21 North America Electrochemical Biosensors Market Outlook, By Immunosensors (2021-2030) ($MN)
• Table 22 North America Electrochemical Biosensors Market Outlook, By Other Diagnosis types (2021-2030) ($MN)
• Table 23 North America Electrochemical Biosensors Market Outlook, By Monitoring (2021-2030) ($MN)
• Table 24 North America Electrochemical Biosensors Market Outlook, By Direct Monitoring (2021-2030) ($MN)
• Table 25 North America Electrochemical Biosensors Market Outlook, By Indirect Monitoring (2021-2030) ($MN)
• Table 26 North America Electrochemical Biosensors Market Outlook, By Application (2021-2030) ($MN)
• Table 27 North America Electrochemical Biosensors Market Outlook, By Healthcare Diagnostics (2021-2030) ($MN)
• Table 28 North America Electrochemical Biosensors Market Outlook, By Point Of Care Testing (2021-2030) ($MN)
• Table 29 North America Electrochemical Biosensors Market Outlook, By Research Laboratories (2021-2030) ($MN)
• Table 30 North America Electrochemical Biosensors Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 31 Europe Electrochemical Biosensors Market Outlook, By Country (2021-2030) ($MN)
• Table 32 Europe Electrochemical Biosensors Market Outlook, By Type (2021-2030) ($MN)
• Table 33 Europe Electrochemical Biosensors Market Outlook, By Diagnosis (2021-2030) ($MN)
• Table 34 Europe Electrochemical Biosensors Market Outlook, By DNA Biosensors (2021-2030) ($MN)
• Table 35 Europe Electrochemical Biosensors Market Outlook, By Glucose Biosensors (2021-2030) ($MN)
• Table 36 Europe Electrochemical Biosensors Market Outlook, By Immunosensors (2021-2030) ($MN)
• Table 37 Europe Electrochemical Biosensors Market Outlook, By Other Diagnosis types (2021-2030) ($MN)
• Table 38 Europe Electrochemical Biosensors Market Outlook, By Monitoring (2021-2030) ($MN)
• Table 39 Europe Electrochemical Biosensors Market Outlook, By Direct Monitoring (2021-2030) ($MN)
• Table 40 Europe Electrochemical Biosensors Market Outlook, By Indirect Monitoring (2021-2030) ($MN)
• Table 41 Europe Electrochemical Biosensors Market Outlook, By Application (2021-2030) ($MN)
• Table 42 Europe Electrochemical Biosensors Market Outlook, By Healthcare Diagnostics (2021-2030) ($MN)
• Table 43 Europe Electrochemical Biosensors Market Outlook, By Point Of Care Testing (2021-2030) ($MN)
• Table 44 Europe Electrochemical Biosensors Market Outlook, By Research Laboratories (2021-2030) ($MN)
• Table 45 Europe Electrochemical Biosensors Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 46 Asia Pacific Electrochemical Biosensors Market Outlook, By Country (2021-2030) ($MN)
• Table 47 Asia Pacific Electrochemical Biosensors Market Outlook, By Type (2021-2030) ($MN)
• Table 48 Asia Pacific Electrochemical Biosensors Market Outlook, By Diagnosis (2021-2030) ($MN)
• Table 49 Asia Pacific Electrochemical Biosensors Market Outlook, By DNA Biosensors (2021-2030) ($MN)
• Table 50 Asia Pacific Electrochemical Biosensors Market Outlook, By Glucose Biosensors (2021-2030) ($MN)
• Table 51 Asia Pacific Electrochemical Biosensors Market Outlook, By Immunosensors (2021-2030) ($MN)
• Table 52 Asia Pacific Electrochemical Biosensors Market Outlook, By Other Diagnosis types (2021-2030) ($MN)
• Table 53 Asia Pacific Electrochemical Biosensors Market Outlook, By Monitoring (2021-2030) ($MN)
• Table 54 Asia Pacific Electrochemical Biosensors Market Outlook, By Direct Monitoring (2021-2030) ($MN)
• Table 55 Asia Pacific Electrochemical Biosensors Market Outlook, By Indirect Monitoring (2021-2030) ($MN)
• Table 56 Asia Pacific Electrochemical Biosensors Market Outlook, By Application (2021-2030) ($MN)
• Table 57 Asia Pacific Electrochemical Biosensors Market Outlook, By Healthcare Diagnostics (2021-2030) ($MN)
• Table 58 Asia Pacific Electrochemical Biosensors Market Outlook, By Point Of Care Testing (2021-2030) ($MN)
• Table 59 Asia Pacific Electrochemical Biosensors Market Outlook, By Research Laboratories (2021-2030) ($MN)
• Table 60 Asia Pacific Electrochemical Biosensors Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 61 South America Electrochemical Biosensors Market Outlook, By Country (2021-2030) ($MN)
• Table 62 South America Electrochemical Biosensors Market Outlook, By Type (2021-2030) ($MN)
• Table 63 South America Electrochemical Biosensors Market Outlook, By Diagnosis (2021-2030) ($MN)
• Table 64 South America Electrochemical Biosensors Market Outlook, By DNA Biosensors (2021-2030) ($MN)
• Table 65 South America Electrochemical Biosensors Market Outlook, By Glucose Biosensors (2021-2030) ($MN)
• Table 66 South America Electrochemical Biosensors Market Outlook, By Immunosensors (2021-2030) ($MN)
• Table 67 South America Electrochemical Biosensors Market Outlook, By Other Diagnosis types (2021-2030) ($MN)
• Table 68 South America Electrochemical Biosensors Market Outlook, By Monitoring (2021-2030) ($MN)
• Table 69 South America Electrochemical Biosensors Market Outlook, By Direct Monitoring (2021-2030) ($MN)
• Table 70 South America Electrochemical Biosensors Market Outlook, By Indirect Monitoring (2021-2030) ($MN)
• Table 71 South America Electrochemical Biosensors Market Outlook, By Application (2021-2030) ($MN)
• Table 72 South America Electrochemical Biosensors Market Outlook, By Healthcare Diagnostics (2021-2030) ($MN)
• Table 73 South America Electrochemical Biosensors Market Outlook, By Point Of Care Testing (2021-2030) ($MN)
• Table 74 South America Electrochemical Biosensors Market Outlook, By Research Laboratories (2021-2030) ($MN)
• Table 75 South America Electrochemical Biosensors Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 76 Middle East & Africa Electrochemical Biosensors Market Outlook, By Country (2021-2030) ($MN)
• Table 77 Middle East & Africa Electrochemical Biosensors Market Outlook, By Type (2021-2030) ($MN)
• Table 78 Middle East & Africa Electrochemical Biosensors Market Outlook, By Diagnosis (2021-2030) ($MN)
• Table 79 Middle East & Africa Electrochemical Biosensors Market Outlook, By DNA Biosensors (2021-2030) ($MN)
• Table 80 Middle East & Africa Electrochemical Biosensors Market Outlook, By Glucose Biosensors (2021-2030) ($MN)
• Table 81 Middle East & Africa Electrochemical Biosensors Market Outlook, By Immunosensors (2021-2030) ($MN)
• Table 82 Middle East & Africa Electrochemical Biosensors Market Outlook, By Other Diagnosis types (2021-2030) ($MN)
• Table 83 Middle East & Africa Electrochemical Biosensors Market Outlook, By Monitoring (2021-2030) ($MN)
• Table 84 Middle East & Africa Electrochemical Biosensors Market Outlook, By Direct Monitoring (2021-2030) ($MN)
• Table 85 Middle East & Africa Electrochemical Biosensors Market Outlook, By Indirect Monitoring (2021-2030) ($MN)
• Table 86 Middle East & Africa Electrochemical Biosensors Market Outlook, By Application (2021-2030) ($MN)
• Table 87 Middle East & Africa Electrochemical Biosensors Market Outlook, By Healthcare Diagnostics (2021-2030) ($MN)
• Table 88 Middle East & Africa Electrochemical Biosensors Market Outlook, By Point Of Care Testing (2021-2030) ($MN)
• Table 89 Middle East & Africa Electrochemical Biosensors Market Outlook, By Research Laboratories (2021-2030) ($MN)
• Table 90 Middle East & Africa Electrochemical Biosensors Market Outlook, By Other Applications (2021-2030) ($MN)

According to Stratistics MRC, the Global Electrochemical Biosensors Market is accounted for $17.27 billion in 2023 and is expected to reach $30.87 billion by 2030 growing at a CAGR of 8.65% during the forecast period. Electrochemical biosensors are analytical tools that combine an electrochemical transducer with a biological recognition component (such as enzymes, antibodies, or DNA) to identify and measure particular analytes or biomolecules. Based on the electrochemical reaction caused by the interaction of the recognition element and the target analyte, they function. These biosensors are frequently used to measure a variety of substances, including biomarkers, pathogens, environmental pollutants, and more, in a selective and sensitive manner.

According to the International Diabetic Federation more than 590 million people are expected to develop diabetes by 2035, implying that the market would increase rapidly throughout the projected period.

Market Dynamics:

Driver:

Rising demand for point-of-care testing

The increased demand for point-of-care testing serves as a key driver in the electrochemical biosensor market. Point-of-care testing offers rapid and convenient diagnostic solutions, enabling healthcare professionals to make real-time decisions at the patient's bedside or in remote settings. Electrochemical biosensors, with their high sensitivity and quick results, are well-suited for these applications. They facilitate early disease detection, continuous monitoring, and timely interventions, particularly in emergency situations and for chronic disease management. The growing emphasis on accessible and affordable healthcare, especially in resource-limited areas, is propelling the adoption of electrochemical biosensors in point-of-care testing, driving market expansion.

Restraint:

Cost constraints

The development of advanced biosensor technologies can be expensive, impacting the affordability of these devices. High production costs can hinder their widespread adoption, especially in resource-limited healthcare settings and emerging markets. Additionally, the need for precise quality control adds to production costs, which further restrains market growth.

Opportunity:

Technological advancements in healthcare sector

Technological advancements in the healthcare sector present a significant opportunity in the electrochemical biosensor market. With the ongoing development of miniaturization, wireless connectivity, and data analytics, biosensors are becoming more sophisticated and user-friendly. These advancements enable real-time monitoring, telehealth applications, and the integration of biosensors into wearable devices, thus enhancing patient care and disease management. Moreover, the convergence of biosensors with emerging technologies like artificial intelligence and the Internet of Things further expands their capabilities, offering opportunities for innovative diagnostic and monitoring solutions.

Threat:

Regulatory challenges for the use of healthcare equipment

Strict regulations for the use of healthcare equipment pose a notable threat to the electrochemical biosensor market. The development and commercialization of biosensors for medical purposes involve navigating a complex web of regulatory requirements, including approvals from health authorities. Compliance with these stringent regulations is time-consuming, costly, and often challenging, potentially delaying product launches and hindering market entry. Moreover, stringent requirements may also discourage smaller players from entering the market.

COVID-19 Impact:

The COVID-19 pandemic has had a positive impact on the electrochemical biosensor market. While there was increased demand for biosensors for rapid and accurate testing of the virus, disruptions in supply chains and clinical operations created challenges. The need for point-of-care testing solutions and the development of biosensors for detecting SARS-CoV-2 antibodies drove innovation. However, the broader market was influenced by delays in research and development activities and supply chain constraints. As the pandemic recedes, the market is expected to rebound with a focus on diverse applications beyond infectious disease diagnostics.

The diagnosis segment is expected to be the largest during the forecast period

The diagnosis segment is predicted to dominate the market due to the growing demand for rapid, accurate, and user-friendly diagnostic solutions. Diagnosis offers high sensitivity and specificity in detecting biomarkers, pathogens, and disease-related molecules. With applications ranging from clinical diagnostics to environmental and food safety, biosensors are invaluable tools for early disease detection, monitoring, and research. Their ability to provide real-time data and point-of-care testing positions for diagnosis is propelling segment expansion.

The point of care testing segment is expected to have the highest CAGR during the forecast period

The point of care testing segment is poised to drive the market during the forecast period, owing to the increasing demand for rapid and decentralized diagnostic solutions. Electrochemical biosensors, with their portability, quick results, and ease of use, are well-suited for POC applications. They empower healthcare professionals to make timely decisions at the patient's side, offering real-time insights for better disease management and early detection. Moreover, POC testing is crucial in resource-limited settings, remote areas, and emergency situations. With a global shift towards accessible and affordable healthcare, the adoption of electrochemical biosensors in POC settings is expected to surge, propelling market growth.

Region with largest share:

During the forecast period, North America is anticipated to account for the largest market owing to regions rising healthcare expenditure and the adoption of point-of-care testing technologies. The presence of major biotechnology and pharmaceutical companies, along with significant investments in healthcare, promotes technological advancements and innovative biosensor applications in the region. Moreover, North America's well-established healthcare system and a growing geriatric population contribute to the market's growth, making it a prominent player in the global electrochemical biosensors market.

Region with highest CAGR:

The electrochemical biosensors market in the Asia Pacific is witnessing substantial growth due to rising healthcare awareness, increasing prevalence of chronic diseases, and a growing focus on early disease detection. With a large and diverse population, the region's demand for diagnostic tools and medical devices is on the rise. Additionally, government initiatives to enhance healthcare infrastructure and technological advancements in biosensor technologies are further driving the market's expansion.

Key players in the market:

Some of the key players in Electrochemical Biosensors market include: Abbott Laboratories, Bayer AG, Bio-Rad Laboratories, Biosensors International Group Ltd., Conductive Technologies Inc., I-SENS, Inc, Medtronics, Philips Healthcare, Roche Holding AG, Siemens Healthineers, Sysmex Corporation and Thermo Fisher Scientific.

Key Developments:

In February 2023, FREDsense Technologies Corp., the leader in field-ready water testing kits that detect chemicals in drinking and wastewater, announced that their platform can detect and measure PFAS in just hours, compared to traditional methods.

In September 2023, Abbott announced it has completed the acquisition of Bigfoot Biomedical, a leader in developing smart insulin management systems for people with diabetes. The transaction expands Abbott's presence in diabetes care, building on its world-leading FreeStyle Libre® portfolio of continuous glucose monitoring technology and furthering the company's efforts to develop connected solutions for making diabetes management even more personal and precise.

Types Covered:

• Diagnosis
• Monitoring

Applications Covered:

• Healthcare Diagnostics
• Point Of Care Testing
• Research Laboratories
• Other Applications

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Application Analysis
• 3.7 Emerging Markets
• 3.8 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Electrochemical Biosensors Market, By Type

• 5.1 Introduction
• 5.2 Diagnosis
  • 5.2.1 DNA Biosensors
  • 5.2.2 Glucose Biosensors
  • 5.2.3 Immunosensors
  • 5.2.4 Other Diagnosis types
• 5.3 Monitoring
  • 5.3.1 Direct Monitoring
  • 5.3.2 Indirect Monitoring

6 Global Electrochemical Biosensors Market, By Application

• 6.1 Introduction
• 6.2 Healthcare Diagnostics
• 6.3 Point Of Care Testing
• 6.4 Research Laboratories
• 6.5 Other Applications

7 Global Electrochemical Biosensors Market, By Geography

• 7.1 Introduction
• 7.2 North America
  • 7.2.1 US
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 Italy
  • 7.3.4 France
  • 7.3.5 Spain
  • 7.3.6 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 Japan
  • 7.4.2 China
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 New Zealand
  • 7.4.6 South Korea
  • 7.4.7 Rest of Asia Pacific
• 7.5 South America
  • 7.5.1 Argentina
  • 7.5.2 Brazil
  • 7.5.3 Chile
  • 7.5.4 Rest of South America
• 7.6 Middle East & Africa
  • 7.6.1 Saudi Arabia
  • 7.6.2 UAE
  • 7.6.3 Qatar
  • 7.6.4 South Africa
  • 7.6.5 Rest of Middle East & Africa

8 Key Developments

• 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 8.2 Acquisitions & Mergers
• 8.3 New Product Launch
• 8.4 Expansions
• 8.5 Other Key Strategies

9 Company Profiling

• 9.1 Abbott Laboratories
• 9.2 Bayer AG
• 9.3 Bio-Rad Laboratories
• 9.4 Biosensors International Group Ltd.
• 9.5 Conductive Technologies Inc.
• 9.6 I-SENS, Inc
• 9.7 Medtronics
• 9.8 Philips Healthcare
• 9.9 Roche Holding AG
• 9.10 Siemens Healthineers
• 9.11 Sysmex Corporation
• 9.12 Thermo Fisher Scientific